TAiloring LImb length based on total small bowel Lengthin Omega-loop gastric bypass suRgery : the TAILOR study
- Conditions
- <p>class III obesity or class II with co-morbidities e.g diabetes, hypertension, sleep apnea, arthrosis</p>
- Registration Number
- NL-OMON27559
- Lead Sponsor
- Medisch Center Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 212
Agreed to have mini-gastric bypass surgery
- Age between 18 and 65
-BMI > 40 kg/m2 or
-BMI > 35 kg/m2 with co-morbidity : diabetes, hypertension, OSAS, arthrosis
-Willing to participate with written informed consent before start of the surgery
-A completely measured total small bowel during surgery
-No pre-operative deficiencies of vit B12, vit D and iron, measured with ferritin
-No use of extra (multi-)vitamin supplements with exception of vit D max 800 IU/day
-Able to swallow the multivitamin FFM WLS primo (tested before surgery)
-BMI > 50 Kg/m2
-Known gastro-intestinal disease or history of gastro-intestinal disease, e.g. celiac disease, inflammatory bowel disease
-Known addiction behaviour
-Suspected compliance problems
-Intolerance to Fitforme Primo multivitamin
-Pregnancy planning within the first two years after surgery
-Renal or hepatic insufficiency
-Former abdominal surgery unabling the measurement of the small bowel during laparoscopic surgery
-Parenteral use of vit B12
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Percent total weight loss (%TWL) at 5 years. Assumptions : Control group : TWL of 35% (SD 12%) Experimental group : TWL of 40% (SD 12 or 9%) (Absolute difference TWL 5% with possible smaller SD) Definition : TWL = ([initial weight – attained weight]/ initial weight) * 100</p>
- Secondary Outcome Measures
Name Time Method